Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Bibliographic Details
Main Authors: Kikuchi, Kayoko, Miyakawa, Yoshitaka, Ikeda, Shunya, Sato, Yuji, Takebayashi, Toru
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/

Similar Items